Regeneron Pharmaceuticals (REGN) Gains from Investment Securities (2010 - 2026)
Regeneron Pharmaceuticals' quarterly Gains from Investment Securities came in at $73.2 million in Q1 2026, up 2387.5% year-on-year from $2.9 million in Q1 2025, and down 85.9% quarter-over-quarter from $519.2 million in Q4 2025.
Regeneron Pharmaceuticals has reported Gains from Investment Securities for 17 years, with the latest figure at $73.2 million in Q1 2026.
- For the quarter ending Q1 2026, Gains from Investment Securities rose 2387.5% year-over-year to $73.2 million; the trailing twelve-month figure through Mar 2026 stood at $608.5 million (down 40.69% YoY), and the FY2025 full-year result was $532.1 million, down 48.29% from the prior year.
- Gains from Investment Securities for Q1 2026 stood at $73.2 million, down from $519.2 million in the prior quarter.
- The five-year high for Gains from Investment Securities was $772.8 million in Q3 2024, with the low at -$237.1 million in Q2 2022.
- Average Gains from Investment Securities over 5 years is $74.5 million, with a median of $3.0 million recorded in 2024.
- Year-over-year, Gains from Investment Securities tumbled 3100.0% in 2025 and soared 2387.5% in 2026.
- Tracing REGN's Gains from Investment Securities over 5 years: stood at -$169.0 million in 2022, then jumped by 110.36% to $17.5 million in 2023, then surged by 1348.0% to $253.4 million in 2024, then surged by 104.89% to $519.2 million in 2025, then tumbled by 85.9% to $73.2 million in 2026.
- The last three Gains from Investment Securities figures came in at $73.2 million (Q1 2026), $519.2 million (Q4 2025), and -$4.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 31.20 Bn | 31.20 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 73.20 Mn |
| Mar 31, 2026 | 73.20 Mn |
| Dec 31, 2025 | 519.20 Mn |
| Dec 31, 2025 | 519.20 Mn |
| Sep 30, 2025 | -4.80 Mn |
| Sep 30, 2025 | -4.80 Mn |
| Jun 30, 2025 | 20.90 Mn |
| Jun 30, 2025 | 20.90 Mn |
| Mar 31, 2025 | -3.20 Mn |
| Mar 31, 2025 | -3.20 Mn |
| Dec 31, 2024 | 253.40 Mn |
| Dec 31, 2024 | 253.40 Mn |
| Sep 30, 2024 | 772.80 Mn |
| Sep 30, 2024 | 772.80 Mn |
| Jun 30, 2024 | 3.00 Mn |
| Jun 30, 2024 | 3.00 Mn |
| Mar 31, 2024 | -100,000.00 |
| Mar 31, 2024 | -100,000.00 |
| Dec 31, 2023 | 17.50 Mn |
| Dec 31, 2023 | 17.50 Mn |
| Sep 30, 2023 | -130.50 Mn |
| Sep 30, 2023 | -130.50 Mn |
| Jun 30, 2023 | 133.70 Mn |
| Jun 30, 2023 | 133.70 Mn |
| Mar 31, 2023 | -20.60 Mn |
| Mar 31, 2023 | -20.60 Mn |
| Dec 31, 2022 | -169.00 Mn |
| Dec 31, 2022 | -169.00 Mn |
| Sep 30, 2022 | -60.70 Mn |
| Sep 30, 2022 | -60.70 Mn |
| Jun 30, 2022 | -237.10 Mn |
| Jun 30, 2022 | -237.10 Mn |
| Mar 31, 2022 | 98.80 Mn |
| Mar 31, 2022 | 98.80 Mn |
| Dec 31, 2021 | 768.10 Mn |
| Dec 31, 2021 | 768.10 Mn |
| Sep 30, 2021 | 642.90 Mn |
| Sep 30, 2021 | 642.90 Mn |
| Jun 30, 2021 | -163.90 Mn |
| Jun 30, 2021 | -163.90 Mn |
| Mar 31, 2021 | -28.70 Mn |
| Mar 31, 2021 | -28.70 Mn |
| Dec 31, 2020 | 28.30 Mn |
| Dec 31, 2020 | 28.30 Mn |
| Sep 30, 2020 | 676.30 Mn |
| Sep 30, 2020 | 676.30 Mn |
| Jun 30, 2020 | 58.80 Mn |
| Jun 30, 2020 | 58.80 Mn |
| Mar 31, 2020 | -82.60 Mn |
| Mar 31, 2020 | -82.60 Mn |
| Dec 31, 2019 | 455.50 Mn |
| Dec 31, 2019 | 455.50 Mn |
| Sep 30, 2019 | -153.70 Mn |
| Sep 30, 2019 | -153.70 Mn |
| Jun 30, 2019 | 16.70 Mn |
| Jun 30, 2019 | 16.70 Mn |
| Mar 31, 2019 | 23.80 Mn |
| Mar 31, 2019 | 23.80 Mn |
| Dec 31, 2018 | -72.70 Mn |
| Dec 31, 2018 | -72.70 Mn |
| Sep 30, 2018 | 27.80 Mn |
| Sep 30, 2018 | 27.80 Mn |
| Jun 30, 2018 | 50.70 Mn |
| Jun 30, 2018 | 50.70 Mn |
| Mar 31, 2018 | 4.20 Mn |
| Mar 31, 2018 | 4.20 Mn |
| Dec 31, 2017 | 754.80 Mn |
| Dec 31, 2017 | 754.80 Mn |
| Sep 30, 2017 | 37.63 Mn |
| Sep 30, 2017 | 37.63 Mn |
| Jun 30, 2017 | -33.68 Mn |
| Jun 30, 2017 | -33.68 Mn |
| Mar 31, 2017 | -3.96 Mn |
| Mar 31, 2017 | -3.96 Mn |
| Dec 31, 2016 | 494.99 Mn |
| Dec 31, 2016 | 494.99 Mn |
| Sep 30, 2016 | -5.79 Mn |
| Sep 30, 2016 | -5.79 Mn |
| Jun 30, 2016 | -3.84 Mn |
| Jun 30, 2016 | -3.84 Mn |
| Mar 31, 2016 | -3.96 Mn |
| Mar 31, 2016 | -3.96 Mn |
| Dec 31, 2015 | 195.46 Mn |
| Dec 31, 2015 | 195.46 Mn |
| Sep 30, 2015 | -1.90 Mn |
| Sep 30, 2015 | -1.90 Mn |
| Jun 30, 2015 | -54.21 Mn |
| Jun 30, 2015 | -54.21 Mn |
| Mar 31, 2015 | 21.19 Mn |
| Mar 31, 2015 | 21.19 Mn |
| Dec 31, 2014 | -253.44 Mn |
| Dec 31, 2014 | -253.44 Mn |
| Sep 30, 2014 | 110.88 Mn |
| Sep 30, 2014 | 110.88 Mn |
| Jun 30, 2014 | 59.07 Mn |
| Jun 30, 2014 | 59.07 Mn |
| Mar 31, 2014 | 5.92 Mn |
| Mar 31, 2014 | 5.92 Mn |
| Dec 31, 2013 | 28.73 Mn |
| Dec 31, 2013 | 28.73 Mn |
| Sep 30, 2013 | 184.68 Mn |
| Sep 30, 2013 | 184.68 Mn |
| Jun 30, 2013 | -21.41 Mn |
| Jun 30, 2013 | -21.41 Mn |
| Mar 31, 2013 | 3.09 Mn |
| Mar 31, 2013 | 3.09 Mn |
| Dec 31, 2012 | -71.48 Mn |
| Dec 31, 2012 | -71.48 Mn |
| Sep 30, 2012 | 82.53 Mn |
| Sep 30, 2012 | 82.53 Mn |
| Jun 30, 2012 | 568,000.00 |
| Jun 30, 2012 | 568,000.00 |
| Mar 31, 2012 | 469,000.00 |
| Mar 31, 2012 | 469,000.00 |
| Dec 31, 2011 | -4.59 Mn |
| Dec 31, 2011 | -4.59 Mn |
| Sep 30, 2011 | -1.29 Mn |
| Sep 30, 2011 | -1.29 Mn |
| Jun 30, 2011 | 101,000.00 |
| Jun 30, 2011 | 101,000.00 |
| Mar 31, 2011 | 1.06 Mn |
| Mar 31, 2011 | 1.06 Mn |
| Dec 31, 2010 | -6.66 Mn |
| Dec 31, 2010 | -6.66 Mn |
| Sep 30, 2010 | 1.00 Mn |
| Sep 30, 2010 | 1.00 Mn |
| Jun 30, 2010 | 1.08 Mn |
| Jun 30, 2010 | 1.08 Mn |
| Mar 31, 2010 | 544,000.00 |
| Mar 31, 2010 | 544,000.00 |